These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1695779)

  • 1. Clinical manifestations of benign prostatic hyperplasia and indications for therapeutic intervention.
    Christensen MM; Bruskewitz RC
    Urol Clin North Am; 1990 Aug; 17(3):509-16. PubMed ID: 1695779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostatectomy in a chronic leukemic patient].
    Banchieri FR; Provana A; Viarengo G
    J Urol Nephrol (Paris); 1972; 78(1):133-7. PubMed ID: 4115510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current status of the treatment and prognosis of the prostatic urine retention].
    Bibus B
    Wien Klin Wochenschr; 1967 Feb; 79(6):105-8. PubMed ID: 4173547
    [No Abstract]   [Full Text] [Related]  

  • 5. Holmium laser enucleation for prostate adenoma greater than 100 gm.: comparison to open prostatectomy.
    Moody JA; Lingeman JE
    J Urol; 2001 Feb; 165(2):459-62. PubMed ID: 11176396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
    Helfand B; Mouli S; Dedhia R; McVary KT
    J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign prostatic hypertrophy.
    O'Brien WM
    Am Fam Physician; 1991 Jul; 44(1):162-71. PubMed ID: 1711771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A self-retaining intraurethral device as an alternative to indwelling catheter and prostatectomy].
    Nissenkorn I; Aronheim M; Sluzker D; Richter S
    Harefuah; 1990 Nov; 119(9):254-6. PubMed ID: 1701751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia in older men.
    Gerber GS
    Clin Geriatr Med; 1998 May; 14(2):317-31. PubMed ID: 9536108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
    Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
    Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of the PCPT trial to finasteride treatment of micturition disorders due to benign prostatic hyperplasia].
    de la Taille A
    Prog Urol; 2008 Apr; 18 Suppl 3():S53-7. PubMed ID: 18455085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for prostatectomy.
    Weinberg SR; Tanenbaum B
    Geriatrics; 1973 Mar; 28(3):143-5. PubMed ID: 4120632
    [No Abstract]   [Full Text] [Related]  

  • 13. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction.
    Marklund-Bau H; Edéll-Gustafsson U; Spångberg A
    Scand J Urol Nephrol; 2007; 41(1):32-41. PubMed ID: 17366100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of prostatic obstruction. A prospective survey.
    Craigen AA; Hickling JB; Saunders CR; Carpenter RG
    J R Coll Gen Pract; 1969 Oct; 18(87):226-32. PubMed ID: 4186545
    [No Abstract]   [Full Text] [Related]  

  • 16. Benign prostatic hyperplasia: treat or wait?
    Davidson JH; Chutka DS
    J Fam Pract; 2008 Jul; 57(7):454-63. PubMed ID: 18625168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
    Kaplan SA; McConnell JD; Roehrborn CG; Meehan AG; Lee MW; Noble WR; Kusek JW; Nyberg LM;
    J Urol; 2006 Jan; 175(1):217-20; discussion 220-1. PubMed ID: 16406915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia.
    Kearney MC; Bingham J; Bergland R; Meade-D'Alisera P; Puchner PJ
    J Urol; 2002 Jun; 167(6):2489-91. PubMed ID: 11992064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can we do better than surgery in the treatment of benign prostatic hypertrophy? Results after 10 years in endoscopic resection and adenomectomy in urination and sexual disorders].
    Coeurdacier P; Staerman F; Corbel L; Cipolla B; Guille F; Lobel B
    Prog Urol; 1993 Dec; 3(6):1016-23; discussion 1021-2. PubMed ID: 7508313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of a metallic prostatic stent].
    Yasumoto R; Yoshihara H; Kishimoto T; Maekawa M
    Hinyokika Kiyo; 1991 Nov; 37(11):1467-70. PubMed ID: 1722635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.